Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Patients with good functional status can be safely discharged on POD1 after tumor craniotomy if the appropriate postoperative criteria have been met.
|
30862575 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Transcription factor 21 (TCF21) is identified as a tumor suppressor in a variety of human tumors.
|
31014118 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In the present study, we define clinical stratification of HGSC tumors through the establishment of standard operating procedures for immunohistochemistry and histochemistry based detection of a panel of biomarkers including TCF21, E-cadherin, PARP1, Slug, AnnexinA2, and hyaluronan.
|
30857227 |
2019 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
|
31312357 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Studying the tumor suppressor TCF21 (ref.
|
30617255 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Ectopic expression of TCF21 in CCA cells inhibited xenograft growth or tumor-associated angiogenesis in vivo and targeted the expression and secretion of proangiogenic factors, VEGFA and PDGF-BB.
|
30920845 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We found that the expression of TCF21 was significantly regulated by its methylation level in patients with NSCLC and was associated with tumor stage, metastasis and invasion.
|
29086202 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The tumor suppressor function of TCF21 has not been functionally addressed in ccRCC cells; we aimed to explore the functional potential of TCF21 expression in ccRCC cells in vitro.
|
29080283 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
After controlling for potentially relevant confounding variables such as patient comorbidities, tumor size, and location, lower extremity soft tissue sarcomas (p = 0.002, odds ratio [OR], 6.4; 95% confidence interval [CI], 1.97-20.84) and elevated POD 1 early morning blood sugars (p < 0.001; OR, 1.1; 95% CI, 1.04-1.11) were associated with increased wound complications postoperatively.
|
29529645 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, we propose using the subtracted expression levels of the <i>TCF21/POD-1</i> genes as a predictor of overall survival (OS) in adult carcinomas and <i>TCF21-NR5A1</i> as a predictor of malignancy for pediatric tumors in patients aged <5 years.
|
29520253 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, mechanistic studies showed that with TCF21 gene overexpressed, the expression of tumor suppressor Kiss-1 was upregulated and epithelial-mesenchymal transition (EMT) related proteins (E-cadherin, N-cadherin, Snail, Twist, and Vimentin) which participate in cancer cell invasion and metastasis, were reversed.
|
29909422 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Overall, our study determined that TCF21, a hypoxia-driven p53 target, functions as a tumor suppressor in UCEC and presents as a therapeutic target for tumor treatment.
|
29608330 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Taken together, these findings support the hypothesis that Transcription Factor 21 is a regulator of steroidogenic factor 1 and is a tumor suppressor gene in pediatric and adult adrenocortical tumors.
|
28658440 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
BACKGROUND The transcription factor 21 (TCF21) gene is believed to be a tumor suppressor gene.
|
28663539 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, TCF21 functions as a tumor suppressor probably through inactivation of PI3K/AKT signaling and inhibition of MMPs.
|
28352192 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Transcription factor 21 (TCF21) functions as a tumor suppressor and is inactivated in several types of cancer.
|
27270650 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, demethylation treatment resulted in re-expression of TCF21 in CRC cell lines, and cellular function experiments revealed that restoration of TCF21 inhibited CRC cell proliferation, promoted apoptosis and suppressed cell invasion and migration, suggesting that TCF21 may function as a tumor suppressor gene, which is downregulated through promoter hypermethylation in CRC development.
|
26435499 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, the low expression of TCF21 mRNA was associated with large tumor size and positive lymph node metastasis.
|
26044559 |
2015 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Integrated analysis of expression and methylation data identified promoter hypermethylation and low expression of the tumor suppressor gene TCF21 (Pod-1/capsulin/epicardin) in all CCSKs except the case with t(10;17)(q22;p13).
|
26158413 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Transcription factor 21 (TCF21) has been identified as a candidate tumor suppressor at 6q23-q24 that is epigenetically inactivated in many types of human cancers.
|
25156819 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A.
|
25087872 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The methylation frequencies of TCF21 were found to be significantly higher in tumors of patients without nicotine abuse (p = 0.030), in HPV-positive tumors (p = 0.014) and in tumors exhibiting over-expression of p16, a protein induced by HPV (p = 0.006).
|
23529585 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Transcription factor 21 (TCF21) has been identified as a candidate tumor suppressor at 6q23-q24 that is epigenetically inactivated in many types of human cancers.
|
22862160 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
TCF21 hypermethylation in a variety of tumor cell lines suggests it may also be a valuable methylation biomarker in other tumor types.
|
20945327 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Transcription factor 21 (TCF21) belongs to the class A of the basic helix-loop-helix family with reported functions in early lung and kidney development as well as tumor suppressor function in the malignancies of the lung and head and neck.
|
21771727 |
2011 |